Patrick Schöffski
Publications by Year
Research Areas
Gastrointestinal Tumor Research and Treatment, Sarcoma Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Renal cell carcinoma treatment, Cancer Genomics and Diagnostics
Most-Cited Works
- → Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma(2019)3,640 cited
- → Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial(2012)2,056 cited
- → Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up(2018)1,598 cited
- → Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial(2012)1,392 cited
- → Cabozantinib in Progressive Medullary Thyroid Cancer(2013)1,201 cited
- → Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial(2014)1,133 cited
- → Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆(2021)909 cited
- → Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer(2004)773 cited
- → Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial(2016)754 cited
- → Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up(2018)751 cited